As an epidemiologist, my interests lie around the "Who, What, Why, How" of childhood eye and vision disorders - developing and undertaking epidemiological and data science studies to generate useful information on who is at risk and the determinants (why?) of those risks, what outcomes are and the determinants of those outcomes, and understanding how we translate these findings into changes in clinical practice and health policy. 

ORCID: https://orcid.org/0000-0002-8933-5864

TEDx Talk: https://www.ted.com/talks/dr_lola_solebo_through_the_eyes_of_a_child

Childhood Uveitis Signs and Symptoms Studies (ChUSS)

These studies aim to understand the determinants of outcome for a rare, potentially blinding childhood inflammatory eye disease, Uveitis: 

The childhood uveitis imaging studies are improving how we phenotype, monitor and treat disease. These studies are partnered by a Citizen Science Zooniverse Study.

The UveQ study is developing a child-reported eye symptom score. 

UNICORNS, the national prospective cohort study, is also undertaking the work necessary to harmonise routinely collected clinical data - work which is necessary for multi-centre rare eye disease studies. In the UK, collectively, rare disease is the commonest cause of childhood blindness. 

IoLunder2

Worldwide, cataract is aleading cause of avoidable childhood blindness. IoLunder2, an internationally unique national observational longitudinal study, has established findings which are informing practice and policy: 

https://www.thelancet.com/doi/story/10.1016/audio.2018.10.31.107423

BCVIS2 

The British Childhood Visual Impairment Blindness study is providing detailed epidemiological data, necessary for planning and evaluating population health and clinical strategies and services. 

Key findings 

Childhood Vision Screening

Findings from our NSC commissioned systematic review into childhood vision screening informed the national Childhood Vision Screening programme. 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60522-5/fulltext

I am have contributed to national & international health policy as a member of the National Screening Committee's Vision Screening Advisory Group and of the World Health Organization's Paediatric Eye Care Interventions Development Group.